Metoclopramide anesthesia short note

Reading File
Reading File
Finding Sources
Searching PubMed

metoclopramide AND anesthesia

Searching the Web

metoclopramide injection prescribing information contraindications tardive dyskinesia FDA

Reading File

Metoclopramide in Anaesthesia

Class: Prokinetic and antiemetic drug. It is a dopamine D2-receptor antagonist, with 5-HT4 agonist and weak 5-HT3 antagonist actions.

Actions

  • Increases lower oesophageal sphincter tone.
  • Increases gastric antral contractions and promotes gastric emptying.
  • Reduces gastric fluid volume but does not reduce gastric acidity.
  • Antiemetic action is through dopamine blockade in the chemoreceptor trigger zone.

Anaesthetic uses

  1. Aspiration prophylaxis: Used in patients at increased risk of regurgitation and aspiration, such as emergency surgery, inadequate fasting, diabetes with gastroparesis, obesity, and obstetric patients when clinically indicated.
  2. Treatment/prevention of nausea and vomiting: May be used perioperatively, though other antiemetics are often preferred for routine PONV prophylaxis.
  3. Facilitates gastric emptying and passage of nasogastric/intestinal tubes in selected patients.

Dose

  • 10 mg IV, usually administered slowly about 30 minutes before induction.
  • Oral dose: 10-15 mg, with variable onset.
  • IV onset is about 1-3 minutes; duration about 1-2 hours.
    Morgan and Mikhail’s Clinical Anesthesiology, 7e, p. 509.

Adverse effects

  • Drowsiness, restlessness, agitation.
  • Abdominal cramps and diarrhoea, especially after rapid IV injection.
  • Extrapyramidal effects: acute dystonia, akathisia, parkinsonism.
  • Tardive dyskinesia with repeated or prolonged exposure.
  • Rarely: neuroleptic malignant syndrome and hyperprolactinaemia.

Contraindications / precautions

  • Gastrointestinal haemorrhage, mechanical obstruction, or perforation.
  • Phaeochromocytoma: may provoke hypertensive crisis.
  • History of tardive dyskinesia or dystonic reaction.
  • Caution with Parkinson disease and concurrent antipsychotic drugs because extrapyramidal toxicity is increased.
  • Antimuscarinics such as atropine and glycopyrrolate antagonise its gastrointestinal prokinetic effect.
Key point: Metoclopramide decreases gastric volume and increases LES tone, but it does not increase gastric pH; therefore, it may be combined with an acid-reducing agent when aspiration prophylaxis is needed. Its prescribing information carries a warning about potentially irreversible tardive dyskinesia with cumulative exposure.
This is a shared conversation. Sign in to Orris to start your own chat.